Shares of Brii Biosciences (BRII-B) plummeted 6.16% during intraday trading on Friday, reflecting significant investor reaction to the company's latest financial disclosure.
The sharp decline followed the company's announcement of its 2025 financial results, which showed a narrowed net loss attributable to owners of 222.6 million yuan, compared to a loss of 508.2 million yuan in the prior year. The company also reported revenue of 18.6 million yuan for the period, a notable increase from nil revenue in 2024.